[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:stat3-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"STAT3 Gene",3,2,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07262983","Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and\u002For Atopic Dermatitis",[12],"Phase 1","RECRUITING","2026-08-26T02:18:46.948970Z","2026-05-05T02:43:29.363269Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT00001467","Genetic Analysis of Immune Disorders",[],"2026-08-26T02:17:05.997056Z","2026-07-19T19:36:05.116913Z",{"nct_id":23,"title":24,"phases":25,"status":27,"updated_at":28,"content_modified":29},"NCT07670156","Upadacitinib in Treatment of JAK\u002FSTAT Pathway Disorders With Activating Mutations",[26],"Phase 1\u002FPhase 2","NOT_YET_RECRUITING","2026-08-26T02:18:16.220328Z","2026-07-05T03:45:20.371272Z"]